Eclitasertib (DNL-758) is a potent receptor-interacting protein kinase 1 ( RIPK1 ) inhibitor with an IC 50 of 0.0375 µΜ.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > RIP kinase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.